Yoji Andrew Minamishima

Yoji Andrew Minamishima

Auto-generated profile, based on publicly available information

Yoji Andrew Minamishima

Department of Biochemistry, Gunma University Graduate School of Medicine, Maebashi, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2000 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
KNKeiichi I. Nakayama
Keiichi I. Nakayama
HNHiroyasu Nagahama
Hiroyasu Nagahama
YMYohji A. Minamishima
Yohji A. Minamishima
MMMasaki Matsumoto
Masaki Matsumoto
INIkuo Nakamichi
Ikuo Nakamichi
SHShigetsugu Hatakeyama
Shigetsugu Hatakeyama

1 May 2004 in Developmental Cell
Verified
Journal Article
Closed access
KNKeiichi I. Nakayama
Keiichi I. Nakayama
HNHiroyasu Nagahama
Hiroyasu Nagahama
YMYohji A Minamishima
Yohji A Minamishima
SMSatoshi Miyake
Satoshi Miyake
NINoriko Ishida
Noriko Ishida
KNKeiichi I Nakayama
Keiichi I Nakayama

15 March 2008 in Blood
Verified
Journal Article
Open access
PDF file
YMYoji Andrew Minamishima
Yoji Andrew Minamishima
JMJavid Moslehi
Javid Moslehi
NBNabeel Bardeesy
Nabeel Bardeesy
DCDarragh Cullen
Darragh Cullen
RBRoderick T. Bronson
Roderick T. Bronson
WKWilliam G. Kaelin
William G. Kaelin
Pharmacologic activation of the heterodimeric HIF transcription factor appears promising as a strategy to treat diseases, such as anemia, myocardial infarction, and stroke, in which tissue hypoxia is a prominent feature. HIF accumulation is normally linked to oxygen availability because an oxygen-dependent posttranslational modification (prolyl hydroxylation) marks the HIFα subunit for polyubiquitination and destruction. Three enzymes (PHD1, PHD2, and PHD3) capable of catalyzing this reaction have been identified, although PHD2 (also called Egln1) appears to be the primary HIF prolyl hydroxylase in cell culture experiments. We found that conditional inactivation of PHD2 in mice is sufficient to activate a subset of HIF target genes, including erythropoietin, leading to striking increases in red blood cell production. Mice lacking PHD2 exhibit premature mortality associated with marked venous congestion and dilated cardiomyopathy. The latter is likely the result of hyperviscosity syndrome and volume overload, although a direct effect of chronic, high-level HIF stimulation on cardiac myocytes cannot be excluded.

24 February 2008 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
AYArthur P. Young
Arthur P. Young
SSSusanne Schlisio
Susanne Schlisio
YMYoji Andrew Minamishima
Yoji Andrew Minamishima
QZQING ZHANG
QING ZHANG
LLLianjie Li
Lianjie Li
WKWilliam G. Kaelin
William G. Kaelin

18 January 2004 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
TOTakao Ohtsuka
Takao Ohtsuka
HRHoon Ryu
Hoon Ryu
YMYohji A. Minamishima
Yohji A. Minamishima
SMSalvador Macip
Salvador Macip
JSJunji Sagara
Junji Sagara
SLSam W. Lee
Sam W. Lee

8 September 2009 in Circulation
Verified
Journal Article
Open access
PDF file
SMShizuka Minamishima
Shizuka Minamishima
MBMasahiko Bougaki
Masahiko Bougaki
Patrick SipsPatrick Sips
Patrick Sips
JYJia De Yu
Jia De Yu
YMYoji Andrew Minamishima
Yoji Andrew Minamishima
FIFumito Ichinose
Fumito Ichinose
Background— Sudden cardiac arrest (CA) is one of the leading causes of death worldwide. We sought to evaluate the impact of hydrogen sulfide (H 2 S) on the outcome after CA and cardiopulmonary resuscitation (CPR) in mouse. Methods and Results— Mice were subjected to 8 minutes of normothermic CA and resuscitated with chest compression and mechanical ventilation. Seven minutes after the onset of CA (1 minute before CPR), mice received sodium sulfide (Na 2 S) (0.55 mg/kg IV) or vehicle 1 minute before CPR. There was no difference in the rate of return of spontaneous circulation, CPR time to return of spontaneous circulation, and left ventricular function at return of spontaneous circulation between groups. Administration of Na 2 S 1 minute before CPR markedly improved survival rate at 24 hours after CPR (15/15) compared with vehicle (10/26; P =0.0001 versus Na 2 S). Administration of Na 2 S prevented CA/CPR-induced oxidative stress and ameliorated left ventricular and neurological dysfunction 24 hours after CPR. Delayed administration of Na 2 S at 10 minutes after CPR did not improve outcomes after CA/CPR. Cardioprotective effects of Na 2 S were confirmed in isolated-perfused mouse hearts subjected to global ischemia and reperfusion. Cardiomyocyte-specific overexpression of cystathionine γ-lyase (an enzyme that produces H 2 S) markedly improved outcomes of CA/CPR. Na 2 S increased phosphorylation of nitric oxide synthase 3 in left ventricle and brain cortex, increased serum nitrite/nitrate levels, and attenuated CA-induced mitochondrial injury and cell death. Nitric oxide synthase 3 deficiency abrogated the protective effects of Na 2 S on the outcome of CA/CPR. Conclusions— These results suggest that administration of Na 2 S at the time of CPR improves outcome after CA possibly via a nitric oxide synthase 3–dependent signaling pathway.